ALICIA GAUTREAU: Open Payments
NPI 1811426554 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 38 payments from 16 companies in 2025. Trend: 2023 $851 · 2024 $743 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| PFIZER INC. | 3 | $54 |
| Electromed, Inc. | 6 | $43 |
| Insmed, Inc. | 2 | $42 |
| Liquidia Technologies, Inc. | 2 | $41 |
| Baxter Healthcare | 2 | $38 |
| Viatris Specialty LLC | 1 | $34 |
Products named: Ohtuvayre, FASENRA, ELIQUIS, OFEV, SMARTVEST, Arikayce, YUTREPIA, ZERBAXA.
Industry payments across LA — which companies pay providers there.
